Zanettini R - Search Results

1

Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy.

Italiano D, Bianchini E, Ilardi M, Cilia R, Pezzoli G, Zanettini R, Vacca L, Stocchi F, Bramanti P, Ciurleo R, Di Lorenzo G, Polimeni G, de Luise C, Ross D, Rijnbeek P, Sturkenboom M, Trifirò G. Italiano D, et al. Among authors: zanettini r. J Neural Transm (Vienna). 2015 Jun;122(6):799-808. doi: 10.1007/s00702-014-1314-z. Epub 2014 Sep 18. J Neural Transm (Vienna). 2015. PMID: 25230720

2

Regression of cardiac valvulopathy related to ergot-derived dopamine agonists.

Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Zanettini R, et al. Cardiovasc Ther. 2011 Dec;29(6):404-10. doi: 10.1111/j.1755-5922.2010.00169.x. Epub 2010 Jun 11. Cardiovasc Ther. 2011. PMID: 20553285 Free article.

3

Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Trifirò G, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R, Sturkenboom MC. Trifirò G, et al. Among authors: zanettini r. Drug Saf. 2012 Feb 1;35(2):159-71. doi: 10.2165/11594940-000000000-00000. Drug Saf. 2012. PMID: 22204718

4

Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Zanettini R, et al. N Engl J Med. 2007 Jan 4;356(1):39-46. doi: 10.1056/NEJMoa054830. N Engl J Med. 2007. PMID: 17202454 Free article.

5

The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.

Mokhles MM, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp Gv, Zanettini R, Sturkenboom MC. Mokhles MM, et al. Among authors: zanettini r. Pharmacol Res. 2012 Mar;65(3):358-64. doi: 10.1016/j.phrs.2011.11.009. Epub 2011 Nov 23. Pharmacol Res. 2012. PMID: 22123498

6

Cardiac rehabilitation and mid-term follow-up after transcatheter aortic valve implantation.

Zanettini R, Gatto G, Mori I, Pozzoni MB, Pelenghi S, Martinelli L, Klugmann S. Zanettini R, et al. J Geriatr Cardiol. 2014 Dec;11(4):279-85. doi: 10.11909/j.issn.1671-5411.2014.04.001. J Geriatr Cardiol. 2014. PMID: 25593575 Free PMC article.

7

Training prescription in patients on beta-blockers: percentage peak exercise methods or self-regulation?

Zanettini R, Centeleghe P, Ratti F, Benna S, Di Tullio L, Sorlini N. Zanettini R, et al. Eur J Prev Cardiol. 2012 Apr;19(2):205-12. doi: 10.1177/1741826711398823. Epub 2011 Feb 28. Eur J Prev Cardiol. 2012. PMID: 21450591 Clinical Trial.

8

[Work capacity and re-entry into the workforce for the cardiac patient].

Zanettini R, Farina G. Zanettini R, et al. Med Lav. 2004 Mar-Apr;95(2):140-4. Med Lav. 2004. PMID: 15218746 Review. Italian.

9

Validity of the Talk Test for exercise prescription after myocardial revascularization.

Zanettini R, Centeleghe P, Franzelli C, Mori I, Benna S, Penati C, Sorlini N. Zanettini R, et al. Eur J Prev Cardiol. 2013 Apr;20(2):376-82. doi: 10.1177/2047487312438982. Epub 2012 Feb 1. Eur J Prev Cardiol. 2013. PMID: 22345697

10

Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen.

Zanettini R, Bettega D, Agostoni O, Ballestra B, del Rosso G, di Michele R, Mannucci PM. Zanettini R, et al. Cardiology. 1997 Sep-Oct;88(5):468-73. doi: 10.1159/000177378. Cardiology. 1997. PMID: 9286510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters